{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:45:03Z","timestamp":1793828703112,"version":"4.6.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004943","name":"Department of Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004943","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.amepre.2019.05.019","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T04:03:51Z","timestamp":1568779431000},"page":"540-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Opioid Prescribing Safety Measures in Medicaid Enrollees With and Without Cancer"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1323-4554","authenticated-orcid":false,"given":"Patience","family":"Moyo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid F.","family":"Gellad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0613-4929","authenticated-orcid":false,"given":"Lindsay M.","family":"Sabik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald T.","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan S.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Donohue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amepre.2019.05.019_bib0001","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/pds.4443","article-title":"Using prescription claims to detect aberrant behaviors with opioids: comparison and validation of 5 algorithms","volume":"28","author":"Rough","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"10.1016\/j.amepre.2019.05.019_bib0002","first-page":"875","article-title":"Prescription opioid quality measures applied among Pennsylvania Medicaid enrollees","volume":"24","author":"Cochran","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"issue":"13","key":"10.1016\/j.amepre.2019.05.019_bib0003","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.amepre.2019.05.019_bib0004","doi-asserted-by":"crossref","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among U.S. veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.amepre.2019.05.019_bib0005","doi-asserted-by":"crossref","first-page":"837","DOI":"10.7326\/M17-3065","article-title":"Patterns of potential opioid misuse and subsequent adverse outcomes in Medicare, 2008 to 2012","volume":"168","author":"Carey","year":"2018","journal-title":"Ann Intern Med"},{"issue":"15","key":"10.1016\/j.amepre.2019.05.019_bib0006","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.amepre.2019.05.019_bib0007","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/jamaoncol.2018.1574","article-title":"Bridging the critical divide in pain management guidelines from the CDC, NCCN, and ASCO for cancer survivors","volume":"4","author":"Meghani","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.amepre.2019.05.019_bib0008","series-title":"Cost Drivers of Cancer Care: A Retrospective Analysis of Medicare and Commercially Insured Population Claim Data 2004\u20132014","author":"Fitch","year":"2016"},{"issue":"4","key":"10.1016\/j.amepre.2019.05.019_bib0009","first-page":"271","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"13","key":"10.1016\/j.amepre.2019.05.019_bib0010","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1002\/cncr.31389","article-title":"Polypharmacy and patterns of prescription medication use among cancer survivors","volume":"124","author":"Murphy","year":"2018","journal-title":"Cancer"},{"issue":"27","key":"10.1016\/j.amepre.2019.05.019_bib0011","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2016.68.5206","article-title":"Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline","volume":"34","author":"Paice","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.amepre.2019.05.019_bib0012","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11916-007-0204-6","article-title":"Opioid misuse in oncology pain patients","volume":"11","author":"Ballantyne","year":"2007","journal-title":"Curr Pain Headache Rep"},{"issue":"5","key":"10.1016\/j.amepre.2019.05.019_bib0013","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jamaoncol.2019.0042","article-title":"U.S. national trends in opioid-related hospitalizations among patients with cancer","volume":"5","author":"Chua","year":"2019","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.amepre.2019.05.019_bib0014","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1526-4637.2012.01414.x","article-title":"Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic pain","volume":"13","author":"Peppin","year":"2012","journal-title":"Pain Med"},{"issue":"36","key":"10.1016\/j.amepre.2019.05.019_bib0015","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2017.74.1363","article-title":"New persistent opioid use among patients with cancer after curative-intent surgery","volume":"35","author":"Lee","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.amepre.2019.05.019_bib0016","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1526-4637.2011.01260.x","article-title":"A history of being prescribed controlled substances and risk of drug overdose death","volume":"13","author":"Paulozzi","year":"2012","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.amepre.2019.05.019_bib0017","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0885-3924(03)00255-0","article-title":"Use of oral and transdermal opioids among patients with metastatic cancer during the last year of life","volume":"26","author":"Berger","year":"2003","journal-title":"J Pain Symptom Manag"},{"issue":"suppl 2","key":"10.1016\/j.amepre.2019.05.019_bib0018","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/pds.3247","article-title":"Identification of metastatic cancer in claims data","volume":"21","author":"Nordstrom","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.amepre.2019.05.019_bib0019","unstructured":"Pharmacy Quality Alliance. PQA opioid core measure set - 2019. www.pqaalliance.org\/assets\/Measures\/PQA_Opioid_Core_Measure_Set_Description.pdf. Updated 2019. Accessed June 10, 2019."},{"issue":"6","key":"10.1016\/j.amepre.2019.05.019_bib0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention's 2016 opioid guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.amepre.2019.05.019_bib0021","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s11606-017-4288-3","article-title":"Prediction model for two-year risk of opioid overdose among patients prescribed chronic opioid therapy","volume":"33","author":"Glanz","year":"2018","journal-title":"J Gen Intern Med"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379719302764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379719302764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:51:46Z","timestamp":1760082706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379719302764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0749379719302764"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2019.05.019","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid Prescribing Safety Measures in Medicaid Enrollees With and Without Cancer","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2019.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}